Authors:
KORTE W
TRUTTMANN B
HEIM C
STANGL U
SCHMID L
KREIENBUHL G
Citation: W. Korte et al., PREOPERATIVE VALUES OF MOLECULAR COAGULATION MARKERS IDENTIFY PATIENTS AT LOW-RISK FOR INTRAOPERATIVE HEMOSTATIC DISORDERS AND EXCESSIVE BLOOD-LOSS, CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 36(4), 1998, pp. 235-240
Citation: W. Korte, VENOOCCLUSIVE DISEASE OF THE LIVER AFTER BONE-MARROW TRANSPLANTATION - IS HYPERCOAGULABILITY REALLY PART OF THE PROBLEM, Blood coagulation & fibrinolysis, 8(7), 1997, pp. 367-381
Authors:
AMBUHL PM
WUTHRICH RP
KORTE W
SCHMID L
KRAPF R
Citation: Pm. Ambuhl et al., PLASMA HYPERCOAGULABILITY IN HEMODIALYSIS-PATIENTS - IMPACT OF DIALYSIS AND ANTICOAGULATION, Nephrology, dialysis, transplantation, 12(11), 1997, pp. 2355-2364
Citation: W. Korte et S. Gordon, CANCER PROCOAGULANT SHARES SIMILARITIES WITH ALBUMIN BUT IS DISTINCT BY BIOCHEMICAL, IMMUNOLOGICAL AND FUNCTIONAL MEASURES, Thrombosis and haemostasis, 1997, pp. 109-109
Citation: J. Lefkowitz et al., PATIENTS WITH A SHORTENED APTT HAVE INCREASED THROMBIN GENERATION, ARE AT INCREASED RISK FOR THROMBOEMBOLIC EVENTS, AND SHOW SEVERAL BIOCHEMICAL DIFFERENCES FROM NORMAL CONTROLS, Thrombosis and haemostasis, 1997, pp. 2474-2474
Citation: W. Korte et al., DAY-TO-DAY TITRATION TO INITIATE TRANSDERMAL FENTANYL IN PATIENTS WITH CANCER PAIN - SHORT-TERM AND LONG-TERM EXPERIENCES IN A PROSPECTIVE-STUDY OF 39 PATIENTS, Journal of pain and symptom management, 11(3), 1996, pp. 139-146
Citation: W. Korte et al., PROPERTIES OF CANCER PROCOAGULANT IN COMPARISON TO RECOMBINANT ALBUMIN AND PROCOAGULANT ALBUMIN, Blood, 88(10), 1996, pp. 2997-2997
Citation: W. Korte et al., PATIENTS WITH A SHORTENED APTT HAVE INCREASED THROMBIN GENERATION ANDARE AT INCREASED RISK FOR THROMBOEMBOLIC EVENTS, Blood, 88(10), 1996, pp. 3061-3061
Citation: W. Korte et L. Schmid, SUPPRESSION OF F-1+2 (THROMBIN) GENERATION IN PATIENTS WITH DVT REQUIRES INCREASED DOSES OF HEPARIN, Blood coagulation & fibrinolysis, 6(7), 1995, pp. 684-686
Citation: W. Korte et al., ARE PROTHROMBIN FRAGMENTS F-1-THERAPY IN PATIENTS WITH DEEP VENOUS THROMBOSIS(2 USEFUL TO MONITOR HEPARIN), Schweizerische medizinische Wochenschrift, 125(9), 1995, pp. 420-423
Citation: W. Korte et R. Morant, TRANSDERMAL FENTANYL IN UNCONTROLLED CANCER PAIN - TITRATION ON A DAY-TO-DAY BASIS AS A PROCEDURE FOR SAFE AND EFFECTIVE DOSE-FINDING - A PILOT-STUDY IN 20 PATIENTS, Supportive care in cancer, 2(2), 1994, pp. 123-127
Citation: W. Korte et A. Feldges, INCREASED PROTHROMBIN ACTIVATION IN A PATIENT WITH CONGENITAL AFIBRINOGENEMIA IS REVERSIBLE BY FIBRINOGEN SUBSTITUTION, The Clinical investigator, 72(5), 1994, pp. 396-398
Authors:
KORTE W
BAUMGARTNER C
FELDGES A
KNOPFL C
LUTZ S
LENZ A
RIESEN W
SCHMID L
Citation: W. Korte et al., COINCIDENCE OF FAMILIAL PLATELET GLYCOPROTEIN IB IX DEFICIENCY (BERNARD-SOULIER SYNDROME), IDIOPATHIC AUTOANTIBODY AGAINST PLATELET GLYCOPROTEIN IB/IX, FAMILIAL APPEARANCE OF ANTIPHOSPHOLIPID ANTIBODIES, AND FAMILIAL FACTOR-XII DEFICIENCY/, Annals of hematology, 68(2), 1994, pp. 101-104
Authors:
KORTE W
FELDGES A
BAUMGARTNE RC
ULLMANN S
NIEDERER V
SCHMID L
Citation: W. Korte et al., INCREASED THROMBIN GENERATION DURING FIBRINOGEN AND PLATELET RECOVERYAS AN EXPLANATION FOR HYPERCOAGULABILITY IN CHILDREN WITH L-ASPARAGINASE THERAPY FOR ALL OR NHL - A PRELIMINARY-REPORT, Klinische Padiatrie, 206(4), 1994, pp. 331-333
Authors:
KORTE W
OTREMBA H
LUTZ S
FURY R
SCHMID L
WEISSERT M
Citation: W. Korte et al., CHILDHOOD STROKE AT 3 YEARS OF AGE WITH TRANSIENT PROTEIN-C DEFICIENCY FAMILIAL ANTIPHOSPHOLIPID ANTIBODIES AND F-XII DEFICIENCY - A FAMILYSTUDY, Neuropediatrics, 25(6), 1994, pp. 290-294
Citation: Pm. Ambuhl et al., CHANGES IN THE LEVEL OF PROTHROMBIN FRAGMENTS (F-1+2) UNDER ANTICOAGULATION WITH HEPARIN DURING HEMODIALYSIS, Kidney international, 45(6), 1994, pp. 1785-1785
Citation: W. Michaeli et W. Korte, BETTER WELD QUALITY IN ULTRASONIC WELDING - FORCE CONTROL USING SERVOVALVE OPENS UP NEW APPROACHES OF PROCESS-CONTROL, Kunststoffe, German plastics, 83(9), 1993, pp. 667-670